Analytical Data
-
Gene name
CysC
- Application
-
Alternative Names
CysC；Adenylyl-sulfate kinase
-
Species
Synechocystis sp
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P72940
-
Expression Region
1-177aa
-
AA Sequence
MQQRGVTIWL TGLSGAGKTT ITHALEKKLR DSGYRLEVLD GDVVRTNLTK GLGFSKEDRD TNIRRIGFVS HLLTRNGVIV LVSAISPYAA IRQEVKHTIG DFLEVFVNAP LAVCEERDVK GLYAKARSGE IKGFTGIDDP YEPPTNPDVE CRTDLEELDE SVGKIWQKLV DLKYIEG
-
Molecular Weight
19.6 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
Cystatin C (CysC) is a notable成员 of the cystatin superfamily of cysteine proteinase inhibitors. It is primarily produced by many tissues, including the liver, and plays a significant role in regulating proteolytic enzyme activity, which is crucial for various physiological processes, including immune response, tissue remodeling, and apoptosis. Research has shown that altered levels of CysC can be linked to various diseases, such as kidney dysfunction, neurodegenerative disorders, and certain types of cancer, making it a valuable biomarker for disease diagnosis and progression. The recombinant production of CysC has garnered attention due to its potential applications in therapeutic development and diagnostic tools. By utilizing advanced recombinant DNA technology, researchers can produce CysC in a controlled and scalable manner, allowing for better study of its structure-function relationships and broader investigation of its biological roles. Furthermore, the study of CysC's interactions with other proteins can provide insights into its function within the complex network of cellular processes. Understanding CysC at a molecular level is essential for harnessing its therapeutic potential, illustrating the importance of ongoing research into CysC recombinant protein for both fundamental biological research and clinical applications.
